<DOC>
	<DOCNO>NCT03106038</DOCNO>
	<brief_summary>The purpose clinical trial study safety efficacy investigational imaging agent delineation/visualization urologic anatomy set minimally invasive surgery .</brief_summary>
	<brief_title>Dose-escalation Study Contrast Agent Delineation Urological Anatomy Minimally Invasive Surgery</brief_title>
	<detailed_description />
	<criteria>Provide write informed consent prior initiation study procedure Are &gt; 18 year age Women consent undergo standard care minimally invasive pelvic surgery ( traditional laparoscopy robotic surgery ) Women expect admitted hospital follow surgery least 24 hour Are unwilling unable provide inform consent . Are unwilling unable comply requirement protocol . History prior urologic surgery . History prior pelvic surgery . History known retroperitoneal fibrosis . Have follow screen laboratory value : Hemoglobin ≤ 8.0 g/dL ; Absolute neutrophil count ( ANC ) ≤ 1500/μL ; Platelet count ≤ 100,000/μL ; Serum creatinine ≥ 1.5 x institutional upper limit normal ( IULN ) creatinine ; Serum bilirubin ≥ 1.5 x IULN ; Aspartate transaminase ( AST serum glutamic oxaloacetic transaminase , SGOT ) ≥ 2x IULN ; • Alanine transaminase ( ALT serum glutamate pyruvate transaminase , SGPT ) ≥ 2 x IULN . Females pregnant , lactating , breastfeed ; Any condition , Investigator 's judgment , would potentially compromise study compliance ability evaluate safety efficacy .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>contrast agent</keyword>
	<keyword>ureter image</keyword>
	<keyword>intraoperative monitoring</keyword>
	<keyword>intraoperative procedure</keyword>
	<keyword>near infrared fluorescence</keyword>
	<keyword>minimally invasive</keyword>
</DOC>